Skip to main content

Stueland Katherine's Form 4 filing

GeneDx Holdings Corp. (WGS) · filed Dec 18, 2025

Accession no.
0001689575-25-000017
Filed
Dec 18, 2025
Trade date
Dec 16, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 12 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.56M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Stueland KatherineCIK 0001689575Director, Officer (CHIEF EXECUTIVE OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 16, 2025Class A Common StockMOption exerciseAcquired+18,750$0.00F1$025,094Direct
Dec 16, 2025Class A Common StockSSaleDisposed−369$138.93F3−$51,265.1724,725Direct
Dec 16, 2025Class A Common StockSSaleDisposed−1,031$140.08F4−$144,422.4823,694Direct
Dec 16, 2025Class A Common StockSSaleDisposed−2,679$141.20F5−$378,274.821,015Direct
Dec 16, 2025Class A Common StockSSaleDisposed−604$142.12F6−$85,840.4820,411Direct
Dec 16, 2025Class A Common StockSSaleDisposed−940$144.27F7−$135,613.819,471Direct
Dec 16, 2025Class A Common StockSSaleDisposed−1,628$145.36F8−$236,646.0817,843Direct
Dec 16, 2025Class A Common StockSSaleDisposed−1,970$146.93F9−$289,452.115,873Direct
Dec 16, 2025Class A Common StockSSaleDisposed−932$148.55F10−$138,448.614,941Direct
Dec 16, 2025Class A Common StockSSaleDisposed−274$149.20F11−$40,880.814,667Direct
Dec 16, 2025Class A Common StockSSaleDisposed−74$150.75−$11,155.514,593Direct
Dec 16, 2025Class A Common StockSSaleDisposed−356$140.95−$50,178.214,237Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 16, 2025Class A Common StockMOption exerciseDisposed−18,750$0.00$093,750Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.65 to $139.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 through 11.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.70 to $140.465, inclusive.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.72 to $141.68, inclusive.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.76 to $142.41, inclusive.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.75 to $144.74, inclusive.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.80 to $145.55, inclusive.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.605 to $147.51, inclusive.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.85 to $148.76, inclusive.

Referenced by the price of 1 transaction in Table I.

F11

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.01 to $149.32, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)